Sign up
Pharma Capital

Genervon consultant to present novel method to test peptide drugs at PhysChem Forum

Genervon Biopharmaceuticals COO Dorothy Ko tells Proactive Investors the company is gearing up for the PhysChem Forum in Basel, Switzerland, on April 17.

Ko says there has been a lack of methodology to test peptide drugs, however, scientific consultant Dr. Klara Volke will be presenting at the forum how she developed a new HPLC testing method on behalf of Genervon.

 

View full GNVR profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.